Skip to main content

It took a petition filed for Nitto Denko Corporation to expose backlogs and pendency at the Indian Patent Office – and force a revisit of expedited applications.

Nitto Denko’s petitions highlighted the extensive backlog and resultant delays in the Indian Patent Office. Beset by underfunding and understaffing the office took anywhere between 8 and 9 years to grant a patent. Compare that to the six months ‘ordinarily’ mandated to issue the First Examination report under the Patent Rules then.

The court after hearing the matter constituted a committee to look into the many recommendations made on behalf of Nitto Denko. Indeed, the door to expedited patents had been opened – and ultimately the Patent Office would receive much-needed reprieve, even if reform in the patent regime would be left wanting.

The committee deliberated out-of-turn patents and recommended adding Rule 24C to the Patent Rules for inventions contributing directly to public interest. That, and the applicant would have to prove resources to commence production within two years from filing.

Aside from inviting discussion on how backlog could be reduced, the petition also heralded change at the Indian Patent Office. The government disbursed an additional 30.96 million rupees ($492 thousand) to increase manpower and halt the attrition from the then-poor remuneration offered to its officers.

The proposed expedited patent is still some way short of accepting urgency – like for instance the US patent office which can be much more flexible in its dispensation. And how much industry, any industry, is able to benefit from strict public interest and capital requirements is one to be seen.

Authored by Pravin Anand.

The article was published in The Patent Lawyer April 2015.

Nitto Denko Corporation v Union of India and Ors

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions
Thought Leadership
•
Oct 15, 2026

First published on Enterprise IT World. Authored by Subroto Kumar Panda Imagine you gave a supersmart robot a credit card and told it to “buy the best

Taming the AI Beast: How Big Companies Build Safe AI Agents
News & Updates, Thought Leadership
•
Oct 14, 2026

Think about the last YouTube video you watched. It might have been a travel vlog, a product review, a legal explainer, a cooking tutorial or a short documentary.

Who Owns a YouTube Video? Copyright Protection for Digital Creators in India
News & Updates, Thought Leadership
•
Oct 09, 2026

For a creator, the product and the person are often indistinguishable. A finance educator’s credibility, a teacher’s cadence, a comedian’s

When Your Persona Becomes Your Business: Personality Rights of Influencers in India